Money & Banking

Covid-19: SBI to reimburse detection test expenses to award staff

Vinson Kurian Thiruvananthapuram | Updated on March 29, 2020 Published on March 29, 2020

The amount being reimbursed is subject to a ceiling of ₹4,500 as prescribed by the Government of India.

The State Bank of India (SBI) will reimburse expenses on Covid-19 detection test undergone by award staff members or their dependent family members on the basis of actual expenses incurred.

Award staff represents that cadre that does not hold the power of attorney that an officer enjoys on behalf of the bank. When such an officer signs on a document, the bank is held bound and liable.

Authorised practitioner

The SBI requires that detection test be advised by a registered medical practitioner. The amount being reimbursed is subject to a ceiling of ₹4,500 as prescribed by the Government of India.

This will include ₹1500 for the screening test in case of suspect cases and an additional ₹3,000 for the confirmation test. The test shall be done only at a government-authorised lab/hospital. If an award staff member or his/her dependent family member tests positive, expenses on domiciliary treatment will also be reimbursed.

With regard to supervising staff members, there is no restriction related to diagnostic test/domiciliary treatment/hospitalisation and as such, reimbursement will be made in the usual manner as per existing instructions. However, the ceiling of ₹4,500 prescribed by the government will be applicable.

The bank says it has taken into account the prevailing world-wide situation of the coronavirus pandemic that could necessitate employees undergo a diagnostic test for detection of the infection.

The reimbursement will be applicable for tests post March 1.

Medical reimbursement scheme

The SBI provides medical facility to award staff and their dependent family under its medical reimbursement scheme. The facility covers diagnostic investigations and domiciliary treatment for specified diseases.

Medical expenses incurred in respect of treatment of these diseases are reimbursed to the extent of 100 per cent of the amount of admissible expenses based on the actual cost of medicines/investigations, and the schedule of reasonable charges standardised for the centre. At present, medical expenses are reimbursed to the award staff for domiciliary treatment in respect of 42 diseases.

The Chief General Manager (HR) will be the competent authority to issue clarifications in the matter. All other terms and conditions applicable to award staff under the bank’s existing scheme shall remain unchanged.

Published on March 29, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.